These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7258754)

  • 41. Endotracheal bretylium tosylate in a canine model.
    Murphy KM; Caplen SM; Nowak RM; Lin WN; Kelly AR; Slocombe R; Tomlanovich MC
    Ann Emerg Med; 1984 Feb; 13(2):87-91. PubMed ID: 6419651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of bretylium tosylate on the intraocular pressure of the rabbit.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Nov; 197(2):153-8. PubMed ID: 1082263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bretylium tosylate in the management of refractory ventricular fibrillation.
    Dhurandhar RW; Teasdale SJ; Mahon WA
    Can Med Assoc J; 1971 Jul; 105(2):161-5 passim. PubMed ID: 5556280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation.
    Euler DE; Zeman TW; Wallock ME; Scanlon PJ
    Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of bretylium tosylate during experimental cardiac arrest.
    DeBehnke DJ
    Am J Emerg Med; 1991 Jul; 9(4):398. PubMed ID: 2054013
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of bretylium tosylate in ventricular fibrillation].
    Arcidiacono R
    Clin Ter; 1978 Feb; 84(3):253-66. PubMed ID: 346298
    [No Abstract]   [Full Text] [Related]  

  • 47. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of bretylium tosylate for ventricular tachycardia.
    Chandrasekaran S; Steinberg JS
    Am J Cardiol; 1999 Jan; 83(1):115-7, A9. PubMed ID: 10073797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

  • 50. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of ventricular fibrillation during hypothermia with bretylium tosylate.
    Buckley JJ; Bosch OK; Bacaner MB
    Anesth Analg; 1971; 50(4):587-93. PubMed ID: 5105113
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of bretylium and lidocaine in the prevention of ventricular fibrillation after aortic cross-clamp release in coronary artery bypass surgery.
    Kirlangitis J; Middaugh R; Knight R; Goglin W; Helsel R; Grishkin B; Briggs R
    J Cardiothorac Anesth; 1990 Oct; 4(5):582-7. PubMed ID: 2132137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
    Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A
    N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of bretylium tosylate for the treatment of premature ventricular contractions.
    Romhilt DW; Bloomfield SS; Lipicky RJ; Welch RM; Fowler NO
    Circulation; 1972 Apr; 45(4):800-7. PubMed ID: 4111476
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
    Dłuzniewski M
    Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of bretylium tosylate on the prevention and treatment of postoperative arrhythmias.
    Castaneda AR; Bacaner MB
    Am J Cardiol; 1970 Apr; 25(4):461-6. PubMed ID: 5438242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.